Zacks Investment Research
18 Mar 2026, 15:36 UTC · 33w ago
Impact · against what's priced in
Lesaka Technologies (LSAK) shows mixed fundamentals with strong EPS growth and reaffirmed guidance offset by a significant revenue decline. Mirion Technologies (MIR) remains under pressure based on quantitative ratings and poor monthly performance.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Lesaka Technologies (LSAK) is expected to report a 75% year-over-year increase in quarterly earnings per share to $0.07.
More positive than 76% of claims this week
Lesaka Technologies' expected quarterly revenues are $99.3 million, representing a 26.8% decrease from the year-ago quarter.
Continue reading
5 related stories
The stock is buoyed by a projected 75% year-over-year EPS increase to $0.07 and reaffirmed FY2026 guidance, though this is tempered by an expected 26.8% decline in quarterly revenue to $99.3 million.
Read from the article alone
No priced-in read yet
The company carries a Zacks Rank #4 (Sell) and has experienced a 17.6% return decline over the past month.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 77% of claims this week
Lesaka Technologies has reaffirmed its full-year 2026 guidance.
More positive than 49% of claims this week
Mirion Technologies (MIR) currently holds a Zacks Rank of #4 (Sell).
More negative than 70% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
27m ago
Zacks Investment Research
17m ago
−6.7%
Price agrees with the score
$17.97 vs $19.26 close before publication (Mar 17) · not market-adjusted
MIR chart →−35.4%
Price is moving against the score
$3.52 vs $5.45 close before publication (Mar 17) · not market-adjusted
LSAK chart →
